Impax Laboratories to Present at the Credit Suisse 2012 Healthcare
HAYWARD, Calif. -- November 08, 2012
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will
present at the Credit Suisse 2012 Healthcare Conference on Wednesday, November
14, at 1:00 p.m. Mountain Standard Time. The conference will be held at the
Arizona Biltmore Hotel located in Phoenix, AZ.
Individuals may listen to the live or an archived presentation made at the
conference, which will be posted in the investor relations section of the
Company’s web site at www.impaxlabs.com. This presentation will be archived on
the Company’s web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty pharmaceutical
company applying its formulation expertise and drug delivery technology to the
development of controlled-release and specialty generics in addition to the
development of branded products. Impax markets its generic products through
its Global Pharmaceuticals division and markets its branded products through
the Impax Pharmaceuticals division. Additionally, where strategically
appropriate, Impax has developed marketing partnerships to fully leverage its
technology platform. Impax Laboratories is headquartered in Hayward,
California, and has a full range of capabilities in its Hayward, Philadelphia
and Taiwan facilities. For more information, please visit the Company's Web
site at: www.impaxlabs.com.
Impax Laboratories, Inc.
Mark Donohue, 215-558-4526
Sr. Director, Investor Relations and Corporate Communications
Press spacebar to pause and continue. Press esc to stop.